| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |